GlaxoSmithKline and AIDS Drugs for Africa What comes to mind when you hear the words “pharmaceutical company”? There are many ways to define a pharmaceutical company. According to the Princeton review‚ a pharmaceutical company is a drug company that makes and sells pharmaceuticals. Another definition for a pharmaceutical company is an industry that develops‚ produces‚ and markets drugs licensed for use as generic and/or brand medications. These companies are subject to a variety of laws and
Premium HIV Immune system AIDS
Anti Aids Drug AZT: How it Works and HIV Resistance Name: Jacob Burbank Student ID: 20456553 TA: Steffie Mendaglio Anti Aids Drug AZT: How it Works Many viruses around through our environment have the capability to infect and reproduce in humans‚ sometime quickly being able to spread over a substantial amount of the population. HIV is a retrovirus which advances into AIDS‚ and it has infected people worldwide‚ most prevalently in Africa. Retroviruses are able to
Premium Antiretroviral drug HIV Virus
HIV/AIDS this week‚ claiming it will be the cheapest such treatment in the world. The country has the world’s largest number of people living with the virus and it hopes this new pill will allow it to treat more patients. In this small ARV (antiretroviral multiple drug therapy) center in the north of Pretoria‚ South Africa‚ a woman looks up at a poster promoting a new treatment for HIV/AIDS. The poster reads "One ARV pill a day. 3 ARV pills in 1‚ taken once a day." For HIV positive South Africans‚ this
Free Africa South Africa HIV
HIV Drugs Viread (chemical name tenofovir disoproxil fumarate) is a significant new drug for the treatment of HIV/AIDS found by Gilead Sciences‚ which received approval from the U.S. Food and Drug Administration for the commercial sale in October 2001.[1] As Gilead made plans to take the drug global in early 2003‚ pricing and distribution became key considerations. There were also many other considerations‚ such as designing an access program in other countries‚ registration of the drug in each
Premium Antiretroviral drug
Christine Carraro 10B Biology ‘Discuss the reasons why the research and development of anti-retroviral drugs (ARVs) has impacted differently on people suffering from HIV/AIDS in developed and developing world’ HIV/AIDS still does not have a know cure‚ but has a treatment that slows down the affects of HIV/AIDS which is called ARV (anti-retroviral drug) The ARV drug is a very “exclusive” drug because as it is very expensive‚ around $400 a month if not more depending on which stage you are in‚ and
Premium Third World First World Second World
African nation desperately needed medicines‚ bothantibiotics to treat the many opportunistic diseases that strike AIDS victims and HIV antiretrovirals thatcan indefinitely prolong the lives of people with AIDS. Unfortunately‚ the people of sub – Saharan Africacould not afford the prices that the major pharmaceutical drug companies charged for their drugs. Themajor drug companies‚ for example‚ charged $10‚000 to $ 15‚000 for a year’s
Premium HIV AIDS Antiretroviral drug
MTCT infections occurred in Africa where AIDS is beginning to reverse decades of steady progress in child survival.2 In high income countries MTCT has been virtually eliminated thanks to effective voluntary testing and counselling‚ access to antiretroviral therapy‚ safe delivery practices‚ and the widespread availability and safe use of breast-milk substitutes. If these interventions were used worldwide‚ they could save the lives of thousands of children each year. How can MTCT be prevented (PMTCT)
Premium AIDS Antiretroviral drug HIV
HIV is a virus that can be mainly spread by a person who has sex or share injection drug equipment such as needles. It is one of the most serious and deadliest diseases in the world. HIV destroys a type of cell in the body called lymphocyte‚ which is part of the immune system (the defense system that fights infection). When these cells destroy the immune system then becomes weak. According to a Canada’s source for HIV‚ “[If] HIV is left untreated your immune system becomes too damaged to defend against
Premium AIDS HIV Immune system
such small variations or mutations in the genetic material of the virus create drug-resistant HIV viruses (adapt to repeated environment changes and resist the antiretroviral treatments)‚ which are tolerant to antiretroviral treatments. Science therefore provides scientists with the tool to come up with new treatments/vaccines (potent and effective‚ taken for shorter periods + decrease side effects) to tackle the drug-resistant HIV strains‚ combating HIV/AIDS and ensuring the safety and health of
Premium AIDS HIV Antiretroviral drug
United States‚ the majority of the problem lies in Africa. Since the 1980s‚ the Western World has made many improvements such as creating antiretroviral drugs that
Premium HIV AIDS Antiretroviral drug